化合物PF-06882961 T12431

Product Introduction
Bioactivity


英文名: PF-06882961

描述: PF-06882961 是一种口服生物可利用的胰高血糖素样肽-1 受体 (GLP-1R) 激动剂。

体内活性: PF-06882961在给药最高剂量下，对大鼠心脏造成轻度至中度损伤，对胸腺（负责管理感染的腺体）产生中度至重度影响，同样引起轻度至中度胃溃疡。[3]

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 125 mg/mL (224.98 mM)


关键字: PF06882961 | PF 06882961 | PF-06882961

相关产品: Lotiglipron | Exenatide | Lixisenatide acetate (320367-13-3 free base) | Glucagon (1-29), bovine, human, porcine hydrochloride | V-0219 hydrochloride | Glucagon-like peptide 1 (1-37), human acetate | Liraglutide | Orforglipron | Glucagon (19-29), human acetate | NNC-0640

相关库: Drug Repurposing Compound Library | Anti-Cancer Drug Library | Clinical Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Anti-Cancer Clinical Compound Library | GPCR Compound Library | Anti-Obesity Compound Library | NO PAINS Compound Library | Bioactive Compound Library

化合物PF-06882961 T12431信息由TargetMol中国为您提供，如您想了解更多关于化合物PF-06882961 T12431报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途